Search

Your search keyword '"Dazzi C."' showing total 37 results

Search Constraints

Start Over You searched for: Author "Dazzi C." Remove constraint Author: "Dazzi C." Publisher elsevier bv Remove constraint Publisher: elsevier bv
37 results on '"Dazzi C."'

Search Results

1. 1207O Bevacizumab + erlotinib vs erlotinib alone as first-line treatment of pts with EGFR mutated advanced non squamous NSCLC: Final analysis of the multicenter, randomized, phase III BEVERLY trial

2. The role of interleukin-8 (IL-8) in predicting the outcome of metastatic colorectal cancer patients treated with aflibercept in combination to FOLFIRI: the FLIBER study

3. P1.01-53 Bone Metastases and Efficacy of Immunotherapy in Patients with Pretreated Advanced Non-Small-Cell Lung Cancer (NSCLC)

4. Role of TP53 mutations in relation to response to anti-ALK agents in EML4-ALK-translocated NSCLC patients

5. P1.13-23 TP53 Mutations as Mechanisms of Primary and Acquired Resistance to Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated NSCLC

6. Phase II study of NAB-paclitaxel in sensitive and refractory relapsed SCLC (NABSTER TRIAL)

7. MA26.02 Upfront or Sequential Strategy for New Generation Anaplastic Lymphoma Kinase (ALK) Inhibitors: An Italian Retrospective Study.

8. P2.13-06 TP53 Status in Relation to Response to Anti-ALK Agents in Patients with EML4-ALK-Translocated NSCLC

9. The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power

10. P1.01-015 Crizotinib in ROS1 Rearranged or MET Deregulated Non-Small-Cell Lung Cancer (NSCLC): Final Results of the METROS Trial

11. Crizotinib in ROS1 rearranged or MET deregulated non-small-cell lung cancer (NSCLC): final results of the METROS trial

13. Frequency of driver mutations in EGFR wt NSCLC using mass spectrometry: Experience of Area Vasta Romagna

14. Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer (SCLC): GOIRC-AIFA FARM6PMFJM trial

15. The role of clinical risk in Low Grade Glioma patients in the era of genomic medicine: a GICNO study

20. Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study

25. Treatment of pelvic osteosarcoma

26. Relief and calcium from gypsum as key factors for net inorganic carbon accumulation in soils of a semiarid Mediterranean environment

27. Evolution of organic carbon pools and microbial diversity in hyperarid anthropogenic soils

28. Ecological restoration in contaminated soils of Kokdzhon phosphate mining area (Zhambyl region, Kazakhstan)

29. In situ remediation of polluted Spolic Technosols using Ca(OH)2 and smectitic marlstone

30. Pedotechnique applications in large-scale farming: Economic value, soil ecosystems services and soil security

31. Aspects of soil phenolic matter (SPM): An explorative investigation in agricultural, agroforestry, and wood ecosystems

32. Integrating soil survey, land use management and political ecology: A case study in a border area between Peru and Ecuador

33. The 'genetic erosion' of the soil ecosystem

34. Is land-use change a cause of loss of pedodiversity? The case of the Mazzarrone study area, Sicily

35. Differences of stabilized organic carbon fractions and microbiological activity along Mediterranean Vertisols and Alfisols profiles

36. Proposal for a new diagnostic horizon for WRB Anthrosols

37. Anthropogenic processes in the evolution of a soil chronosequence on marly-limestone substrata in an Italian Mediterranean environment

Catalog

Books, media, physical & digital resources